October 2009 - Volume 52 - Issue 2 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 9 Next
Author Name Article
Adewole, Isaac MD

Clinical and Genotypic Findings in HIV-Infected Patients With the K65R Mutation Failing First-Line Antiretroviral Therapy in Nigeria

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Aissani, Brahim PhD

The Major Histocompatibility Complex Conserved Extended Haplotype 8.1 in AIDS-Related Non-Hodgkin Lymphoma

Free Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Alfaro, Raul M MS

Gemfibrozil Concentrations Are Significantly Decreased in the Presence of Lopinavir-Ritonavir

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Ambinder, Richard F MD, PhD

The Major Histocompatibility Complex Conserved Extended Haplotype 8.1 in AIDS-Related Non-Hodgkin Lymphoma

Free Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
and APIN Plus/Harvard PEPFAR Team

Clinical and Genotypic Findings in HIV-Infected Patients With the K65R Mutation Failing First-Line Antiretroviral Therapy in Nigeria

Free Access
Abstract
PDF
+ Favorites
Request Permissions
and the Study 934 Team

Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naïve Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With...

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Anderson, Joseph S PhD

Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Asboe, David MD

Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Back, David PhD

Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Badri, Sheila MD

Evaluation of Adherence and Factors Affecting Adherence to Combination Antiretroviral Therapy Among White, Hispanic, and Black Men in the MACS Cohort

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Bangsberg, David R MD, MPH

Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Bartholow, Brad N PhD

HIV Testing Outside of the Study Among Men Who Have Sex With Men Participating in an HIV Vaccine Efficacy Trial

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Bauer, Gerhard MD

Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Bedimo, Roger J MD, MS, FACP

Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Boffito, Marta MD, PhD

Pharmacokinetics and Safety of Etravirine Administered Once or Twice Daily After 2 Weeks Treatment With Efavirenz in Healthy Volunteers

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Breen, Elizabeth C PhD

The Major Histocompatibility Complex Conserved Extended Haplotype 8.1 in AIDS-Related Non-Hodgkin Lymphoma

Free Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Brown, Todd MD, PhD

Evaluation of Adherence and Factors Affecting Adherence to Combination Antiretroviral Therapy Among White, Hispanic, and Black Men in the MACS Cohort

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Burger, David M PharmD, PhD

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Busse, Kristin H PharmD

Gemfibrozil Concentrations Are Significantly Decreased in the Presence of Lopinavir-Ritonavir

Free Access
Abstract
PDF
+ Favorites
Request Permissions
Canassa, Paulo Guilherme F MSc

Profile of Adherence to Highly Active Antiretroviral Therapy of Patients Older Than 50 Years Old

Free Access
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 9 Next